Cell plasticity and taxanes resistance in metastatic prostate cancer: ESRP1 as a predictive biomarker of taxane response

N. Jimenez, O. Reig, R. Montalbo, M. Mila-Guasch, L. Nadal-Dieste, I. Victoria, A. Font, A. Rodriguez-Vida, J. Carles, C. Suarez, M. Domenech, N. Sala-Gonzalez, P. L. Fernandez, A. Prat, M. Marin-Aguilera, B. Mellado

Research output: Contribution to journalArticleResearchpeer-review

Original languageEnglish
Pages (from-to)785-785
Number of pages1
JournalAnn. Oncol.
Volume30
Publication statusPublished - Oct 2019

Cite this

Jimenez, N., Reig, O., Montalbo, R., Mila-Guasch, M., Nadal-Dieste, L., Victoria, I., Font, A., Rodriguez-Vida, A., Carles, J., Suarez, C., Domenech, M., Sala-Gonzalez, N., Fernandez, P. L., Prat, A., Marin-Aguilera, M., & Mellado, B. (2019). Cell plasticity and taxanes resistance in metastatic prostate cancer: ESRP1 as a predictive biomarker of taxane response. Ann. Oncol., 30, 785-785.